G. M. Frampton, A. Fichtenholtz, G. A. Otto, K. Wang, S. R. Downing et al., Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing, Nat Biotechnol, vol.31, issue.11, p.24142049, 2013.

P. J. Stephens, P. S. Tarpey, H. Davies, P. Van-loo, C. Greenman et al., The landscape of cancer genes and mutational processes in breast cancer, Nature, vol.486, issue.7403, p.22722201, 2012.

, Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma, Nature, vol.513, issue.7517, p.25079317, 2014.

K. L. Kanchi, K. J. Johnson, C. Lu, M. D. Mclellan, M. D. Leiserson et al., Integrated analysis of germline and somatic variants in ovarian cancer, Nat Commun, vol.5, p.24448499, 2014.

D. C. Koboldt, K. M. Steinberg, D. E. Larson, R. K. Wilson, and E. R. Mardis, The next-generation sequencing revolution and its impact on genomics, Cell, vol.155, issue.1, p.24074859, 2013.

M. S. Lawrence, P. Stojanov, P. Polak, G. V. Kryukov, K. Cibulskis et al., Mutational heterogeneity in cancer and the search for new cancer-associated genes, Nature, vol.499, issue.7457, p.23770567, 2013.

D. C. Koboldt, Q. Zhang, D. E. Larson, D. Shen, M. D. Mclellan et al., VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing, Genome Res, vol.22, issue.3, p.22300766, 2012.

D. E. Larson, C. C. Harris, K. Chen, D. C. Koboldt, T. E. Abbott et al., SomaticSniper: identification of somatic point mutations in whole genome sequencing data, Bioinformatics, vol.28, issue.3, p.22155872, 2012.

A. Li, Y. Liu, Q. Zhao, H. Feng, L. Harris et al., Genome-wide identification of somatic aberrations from paired normal-tumor samples, PLoS One, vol.9, issue.1, p.24498045, 2014.

A. Roth, J. Ding, R. Morin, A. Crisan, G. Ha et al., JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data. Bioinformatics, vol.28, p.22285562, 2012.

S. A. Forbes, N. Bindal, S. Bamford, C. Cole, C. Y. Kok et al., COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer, Nucleic Acids Res, vol.39, p.20952405, 2011.

S. Hiltemann, G. Jenster, J. Trapman, P. Van-der-spek, and A. Stubbs, Discriminating somatic and germline mutations in tumor DNA samples without matching normals, Genome Res, vol.25, issue.9, p.26209359, 2015.

A. B. Olshen, E. S. Venkatraman, R. Lucito, and M. Wigler, Circular binary segmentation for the analysis of array-based DNA copy number data, Biostatistics, vol.5, issue.4, p.15475419, 2004.

M. Plummer, JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling, Proceedings of the 3rd International Workshop on Distributed Statistical Computing, 2003.

P. Van-loo, S. H. Nordgard, O. C. Lingjaerde, H. G. Russnes, I. H. Rye et al., Allele-specific copy number analysis of tumors, Proc Natl Acad Sci U S A, vol.107, issue.39, p.20837533, 2010.

S. L. Carter, K. Cibulskis, E. Helman, A. Mckenna, H. Shen et al., Absolute quantification of somatic DNA alterations in human cancer, Nat Biotechnol, vol.30, issue.5, p.22544022, 2012.

Y. Li and X. Xie, Deconvolving tumor purity and ploidy by integrating copy number alterations and loss of heterozygosity, Bioinformatics, vol.30, issue.15, p.24695406, 2014.

M. Rasmussen, M. Sundstrom, G. Kultima, H. Botling, J. Micke et al., Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity, Genome Biol, vol.12, issue.10, p.22023820, 2011.

S. Vignot, G. M. Frampton, J. C. Soria, R. Yelensky, F. Commo et al., Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer, J Clin Oncol, vol.31, issue.17, p.23630207, 2013.

S. Vignot, C. Lefebvre, G. M. Frampton, G. Meurice, R. Yelensky et al., Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles, Eur J Cancer, vol.51, issue.7, p.25797355, 2015.

S. Jones, V. Anagnostou, K. Lytle, S. Parpart-li, M. Nesselbush et al., Personalized genomic analyses for cancer mutation discovery and interpretation, Sci Transl Med, vol.7, issue.283, p.25877891, 2015.
DOI : 10.1126/scitranslmed.aaa7161
URL : http://europepmc.org/articles/pmc4442685?pdf=render

K. T. Bieging, S. S. Mello, and L. D. Attardi, Unravelling mechanisms of p53-mediated tumour suppression, Nat Rev Cancer, vol.14, issue.5, p.24739573, 2014.
DOI : 10.1038/nrc3711
URL : http://europepmc.org/articles/pmc4049238?pdf=render

R. Jeselsohn, R. Yelensky, G. Buchwalter, G. Frampton, F. Meric-bernstam et al., Emergence of constitutively active estrogen receptor-alpha mutations in pretreated advanced estrogen receptor-positive breast cancer, Clin Cancer Res, vol.20, issue.7, p.24398047, 2014.

J. S. Ross, K. Wang, L. M. Gay, R. N. Al-rohil, T. Nazeer et al., A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma, Clin Cancer Res, vol.20, issue.1, p.24192927, 2014.